Literature DB >> 21273413

Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior.

Anton N M Schoffelmeer1, Benjamin Drukarch, Taco J De Vries, François Hogenboom, Dustin Schetters, Tommy Pattij.   

Abstract

Because insulin acutely enhances the function of dopamine transporters, the tyrosine kinase receptors activated by this hormone may modulate transporter-dependent neurochemical and behavioral effects of psychoactive drugs. In this respect, we examined the effects of insulin on exocytotic monoamine release and the efficacy of the monoamine transporter blocker cocaine in rat nucleus accumbens. Whereas insulin reduced electrically evoked exocytotic [(3)H]dopamine release in nucleus accumbens slices, the hormone potentiated the release-enhancing effect of cocaine thereon. The phosphatidylinositol 3-kinase inhibitor LY294002 abolished these effects, indicating the involvement of insulin receptors. Similar insulin effects were observed on the release of [(3)H]norepinephrine in nucleus accumbens slices, but not on that of [(3)H]serotonin, and were also apparent in medial prefrontal cortex slices. As might then be expected, insulin also potentiated the dopamine and norepinephrine release-enhancing effects of the selective monoamine uptake inhibitors GBR12909 and desmethylimipramine, respectively. In subsequent behavioral experiments, we investigated the role of insulin in motor impulsivity that depends on monoamine neurotransmission in the nucleus accumbens. Intracranial administration of insulin in the nucleus accumbens alone reduced premature responses in the five-choice serial reaction time task and enhanced the stimulatory effect of peripheral cocaine administration on impulsivity, resembling the observed neurochemical effects of the hormone. In contrast, cocaine-induced locomotor activity remained unchanged by intra-accumbal insulin application. These data reveal that insulin presynaptically regulates cocaine-sensitive monoamine transporter function in the nucleus accumbens and, as a consequence, impulsivity. Therefore, insulin signaling proteins may represent targets for the treatment of inhibitory control deficits such as addictive behaviors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273413      PMCID: PMC6623632          DOI: 10.1523/JNEUROSCI.3779-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

Review 1.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  A modified adjusting delay task to assess impulsive choice between isocaloric reinforcers in non-deprived male rats: effects of 5-HT₂A/C and 5-HT₁A receptor agonists.

Authors:  Angelo Blasio; Aditi R Narayan; Barbara J Kaminski; Luca Steardo; Valentina Sabino; Pietro Cottone
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

Review 3.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

4.  Interactions between insulin and diet on striatal dopamine uptake kinetics in rodent brain slices.

Authors:  Jyoti C Patel; Melissa A Stouffer; Maria Mancini; Charles Nicholson; Kenneth D Carr; Margaret E Rice
Journal:  Eur J Neurosci       Date:  2018-08-01       Impact factor: 3.386

Review 5.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

6.  A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis.

Authors:  Shang Ma; Devi Santhosh; Peeyush Kumar T; Zhen Huang
Journal:  Dev Cell       Date:  2017-05-22       Impact factor: 12.270

7.  PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.

Authors:  David E Kemp; Martha Schinagle; Keming Gao; Carla Conroy; Stephen J Ganocy; Faramarz Ismail-Beigi; Joseph R Calabrese
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 8.  An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.

Authors:  Ilse van de Vondervoort; Geert Poelmans; Armaz Aschrafi; David L Pauls; Jan K Buitelaar; Jeffrey C Glennon; Barbara Franke
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

9.  Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.

Authors:  J L Harenza; P P Muldoon; M De Biasi; M I Damaj; M F Miles
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

10.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.